CBST SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of the Board of Directors of Cubist Pharmaceuticals, In...
December 10 2014 - 12:51PM
Business Wire
Levi & Korsinsky is investigating the Board of Directors of
Cubist Pharmaceuticals, Inc. (“Cubist Pharmaceuticals” or “the
Company”) (NasdaqGS:CBST) for possible breaches of fiduciary duty
and other violations of state law in connection with the sale of
the Company to Merck & Co.
Click here to learn more about the investigation:
http://zlk.9nl.com/cubist-pharmaceuticals-cbst.
Under the terms of the transaction, Cubist Pharmaceuticals
shareholders will $102.00 in cash for each share of Cubist
Pharmaceuticals common stock they own. The investigation concerns
whether the Board of Cubist Pharmaceuticals breached their
fiduciary duties to stockholders by failing to adequately shop the
Company before agreeing to enter into this transaction, and whether
Merck & Co. is underpaying for Cubist Pharmaceuticals
shares.
If you own Cubist Pharmaceuticals common stock and wish to
obtain additional information, please contact Joseph E. Levi, Esq.
either via email at jlevi@zlk.com or by telephone at (212)
363-7500, toll-free: (877) 363-5972, or visit
http://zlk.9nl.com/cubist-pharmaceuticals-cbst.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, Connecticut and Washington D.C. The firm’s
attorneys have extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors
throughout the nation in securities and shareholder lawsuits. For
more information, please feel free to contact any of the attorneys
listed below. Attorney advertising. Prior results do not guarantee
similar outcomes.
Levi & Korsinsky, LLPJoseph Levi, Esq.Eduard Korsinsky,
Esq.Tel: 212-363-7500Toll Free: 877-363-5972Fax:
866-367-6510www.zlk.com